Drug
Diaminohydroxypropanetetraacetic acid clinical trials
Keep track of what changes. Save the diaminohydroxypropanetetraacetic acid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStudies by the year they started
6 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 4
Abbott Medical Devices (1) · Boston Scientific Corporation (1) · Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland (1) · Vincent ROULE (1) · Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o. (1) · HonorHealth Research Institute (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses diaminohydroxypropanetetraacetic acid is read from its arms, and is right about nine times in ten.
Testing it · 6
- Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)RecruitingPhase 3Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.NCT07195149Written as DAPT (Low-Dose Aspirin 75 mg + Prasugrel 10 mg)
- Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCINot yet recruitingPhase 3Vincent ROULENCT07164859Written as short dual antiplatelet therapy (DAPT) duration
- SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet TherapyTerminatedPhase 2HonorHealth Research InstituteNCT03606642Written as Dual Antiplatelet (DAPT) Therapy
- XIENCE 28 USA StudyCompletedNot applicableAbbott Medical DevicesNCT03815175Written as DAPT (aspirin and/or P2Y12 receptor inhibitor)
- EVOLVE Short DAPT StudyCompletedPhase 4Boston Scientific CorporationNCT02605447Written as 3 months of dual antiplatelet therapy (DAPT)
- DES Versus BiOSS LIM - POLBOS II StudyCompletedPhase 4Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, PolandNCT02198300Written as Dual antipletlet therapy (DAPT)
As the comparator · 6 — what is tested is compared with diaminohydroxypropanetetraacetic acid
- Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)RecruitingNot applicableGan LijunNCT07587099Written as Dual antiplatelet therapy (DAPT)
- Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)RecruitingPhase 4J.P.S HenriquesNCT06916520Written as Dual Antiplatelet (DAPT) Therapy
- Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)RecruitingNot applicableFondazione Ricerca e Innovazione Cardiovascolare ETSNCT06535568Written as Dual antiplatelet therapy (DAPT)
- Rivaroxaban for Slow Coronary Flow After PCI in STEMINot yet recruitingPhase 4Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT07195812Written as Dual Antiplatelet (DAPT) Therapy
- Personalization of Long-Term Antiplatelet Therapy - RAPID EXTENDTerminatedPhase 4Ottawa Heart Institute Research CorporationNCT03729401Written as Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81 mg + Ticagrelor 60mg twice daily
- ACCEL-LOADING-ACS StudyCompletedPhase 4Gyeongsang National University HospitalNCT01354808Written as Dual Anti-Platelet Therapy (DAPT)
Codes
What other systems call diaminohydroxypropanetetraacetic acid · ClinicalTrials.gg INT015785
- RxNorm 1659205One source FDA
- Wikidata Q27271662diaminohydroxypropanetetraacetic acidOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 1659205 | — | One source FDA |
| Wikidata | Q27271662 | diaminohydroxypropanetetraacetic acid | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.